Pantheon Healthcare Group announced today the acquisition of Ingegneria Biomedica Santa Lucia S.p.A. (IBSL), a key Italian-based provider of clinical engineering and a large range of biomedical equipment services, from Gruppo Giglio.
Backed by the Permira Funds, the acquisition is part of Pantheon’s continued geographic and modality growth strategy which launched in August 2014 with the acquisition of Asteral Limited and Medical Equipment Solutions and Applications (MESA); two leading independent healthcare service companies operating within the European market. The combination created Europe’s first integrated multi-vendor healthcare service platform for procuring, commissioning, managing and maintaining biomedical devices and diagnostic imaging equipment within public- and private-sector hospitals and clinics.
IBSL was born in 1997 from the entrepreneurial idea of Sergio and Bruno Giglio’s long customer-centric experience with outsourcing options for heating systems. Their biomedical business quickly grew to become one of the leading clinical engineering service providers in Italy, providing direct maintenance to biomedical systems within hospitals and clinics across Italy. In the ensuing years, IBSL integrated further management expertise and technical competences through the acquisition of D&D Med. Com., Ra.se.co, Gidea Alta Tecnologia and Te.Mo.Sa, further strengthening its position in clinical engineering and expanding its reach in the sector of diagnostic imaging equipment and outsourcing services.
Thanks to an outstanding managerial team, led by Alessandro Dogliani, Davide Gagliardi, Antonio Marino, Angelo Deantoni and Enrico Labella, together with about 300 technicians and highly-qualified engineers directly operating within hospitals, IBSL delivers high quality, affordable clinical engineering services, comprehensive solutions for the supply and maintenance of diagnostic imaging equipment as well as full-service outsourcing opportunities for Radiology departments, currently serving more than 60 hospitals, research facilities and other clinical providers in Italy.
The acquisition of IBSL strengthens Pantheon’s position as a leading independent pan-European healthcare provider of complete managed solutions for the lifecycle of medical technologies. With a strong focus on the maintenance, management and sale of equipment for hospitals and diagnostic centres, Pantheon provides central solutions for markets increasingly requiring comprehensive outsourcing provisions and managed services. The combination of IBSL and Pantheon will extend the service offering of the Group, providing a wider variety of equipment services and products and strengthening Pantheon’s presence in Italy, a key country for its international business development.
Since its inception in August 2014, Pantheon has continued its growth both organically and though the acquisition of three key vendor-independent high technology equipment service providers: MVS in Poland, Spintech in Turkey, and Sigil in France.